Medical Device Network on MSN
FDA approves Medtronic’s urinary incontinence treatment device
Implantation of the device is minimally invasive, requiring no sedation or imaging, and is conducted near the ankle.
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
MedPage Today on MSN
FDA Approves Nerve Stimulator for Bladder Control
Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate ...
Analysts said Altaviva is an attractive option compared to rival products, informing their belief that Medtronic can ...
Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting ...
Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...
Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...
Medtronic (NYSE: MDT) today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.
In November, the Food and Drug Administration (FDA) approved r-SNM, the first rechargeable sacral nerve stimulator cleared for full-body MRI scans, and sales results from the initial launch were ...
Bladder leakage is a problem for 60-percent of women. These kinds of incontinence issues can be a big problem, and significantly impact quality of life. Sarah Avrech is a mom of three. She started ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback